China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report 2018

China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report 2017

1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Overview

1.1 Product Overview and Scope of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

1.2 Classification of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Product Category

1.2.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Comparison by Type (2012-2022)

1.2.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Market Share by Type in 2016

1.2.3 Preface

1.2.4 Eluxadoline

1.2.5 Alosetron

1.2.6 Rifaximin

1.2.7 Loperamide

1.2.8 Diphenoxylate + Atropine

1.2.9 Dicyclomine and Hyoscyamine

1.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Application/End Users

1.3.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Market Share Comparison by Applications (2012-2022)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Region

1.4.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) Comparison by Region (2012-2022)

1.4.2 South China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Status and Prospect (2012-2022)

1.4.3 East China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Status and Prospect (2012-2022)

1.4.4 Southwest China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Status and Prospect (2012-2022)

1.4.5 Northeast China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Status and Prospect (2012-2022)

1.4.6 North China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Status and Prospect (2012-2022)

1.4.7 Central China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Status and Prospect (2012-2022)

1.5 China Market Size (Sales and Revenue) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2012-2022)

1.5.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%)(2012-2022)

1.5.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competition by Players/Manufacturers

2.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Share by Players/Manufacturers (2012-2017)

2.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (USD/Unit) by Players/Manufacturers (2012-2017)

2.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competitive Situation and Trends

2.4.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Concentration Rate

2.4.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share of Top 3 and Top 5 Players/Manufacturers

2.4.3 Mergers & Acquisitions, Expansion in China Market

2.5 China Players/Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base Distribution, Sales Area, Product Types

3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue by Region (2012-2017)

3.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Market Share by Region (2012-2017)

3.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Market Share by Region (2012-2017)

3.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"

4.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Market Share by Type/ Product Category (2012-2017)

4.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Market Share by Type (2012-2017)

4.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Type (2012-2017)

4.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"

5.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Market Share by Application (2012-2017)

5.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (%) by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players/Suppliers Profiles and Sales Data

6.1 Astellas Pharmaceuticals

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.1.4 Main Business/Business Overview

6.2 Actavis

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.2.4 Main Business/Business Overview

6.3 Pfizer

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.3.4 Main Business/Business Overview

6.4 GlaxoSmithKline

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.4.4 Main Business/Business Overview

6.5 Salix Pharmaceuticals Ltd

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.5.4 Main Business/Business Overview

6.6 AstraZenenca

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.6.4 Main Business/Business Overview

...

7 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Cost Analysis

7.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Sales and Revenue) Forecast (2017-2022)

11.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD) Forecast (2017-2022)

11.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast by Type (2017-2022)

11.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast by Application (2017-2022)

11.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

Figure Global and China Market Size (Million USD) Comparison (2012-2022)

Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type

Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Application (2016-2022)

Figure Product Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Market Share by Types in 2016

Figure Preface Product Picture

Figure Eluxadoline Product Picture

Figure Alosetron Product Picture

Figure Rifaximin Product Picture

Figure Loperamide Product Picture

Figure Diphenoxylate + Atropine Product Picture

Figure Dicyclomine and Hyoscyamine Product Picture

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Comparison by Application (2012-2022)

Figure China Sales Market Share (%) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application in 2016

Figure Hospitals Examples

Table Key Downstream Customer in Hospitals

Figure Clinics Examples

Table Key Downstream Customer in Clinics

Figure Others Examples

Table Key Downstream Customer in Others

Figure South China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure East China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Northeast China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure North China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Central China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%)(2012-2022)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (%)(2012-2022)

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales of Key Players/Manufacturers (2012-2017)

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share (%) by Players/Manufacturers

Figure 2017 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share (%) by Players/Manufacturers

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Players/Manufacturers (2012-2017)

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) by Players/Manufacturers

Figure 2017 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) by Players/Manufacturers

Table China Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price of Key Players/Manufacturers (2012-2017)

Figure China Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price of Key Players/Manufacturers in 2016

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share of Top 3 Players/Manufacturers

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share of Top 5 Players/Manufacturers

Table China Players/Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base Distribution and Sales Area

Table China Players/Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Regions (2012-2017)

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share (%) by Regions (2012-2017)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share (%) by Regions (2012-2017)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) by Regions in 2016

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Market Share by Regions (2012-2017)

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) by Regions (2012-2017)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) by Regions (2012-2017)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) by Regions in 2016

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Regions (2012-2017)

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Type (2012-2017)

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share (%) by Type (2012-2017)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share (%) by Type (2012-2017)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) by Type in 2016

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Market Share by Type (2012-2017)

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) by Type (2012-2017)

Figure Revenue Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2012-2017)

Figure Revenue Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2016

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Types (2012-2017)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (%) by Type (2012-2017)

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Applications (2012-2017)

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) by Applications (2012-2017)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) by Application (2012-2017)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) by Application in 2016

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (%) by Application (2012-2017)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (%) by Application (2012-2017)

Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information List

Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) in China (2012-2017)

Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) in China (2012-2017)

Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information List

Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) in China (2012-2017)

Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) in China (2012-2017)

Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information List

Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) in China (2012-2017)

Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) in China (2012-2017)

Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information List

Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%)(2012-2017)

Figure GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) in China (2012-2017)

Figure GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) in China (2012-2017)

Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information List

Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) in China (2012-2017)

Figure Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) in China (2012-2017)

Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information List

Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%)(2012-2017)

Figure AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (%) in China (2012-2017)

Figure AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (%) in China (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Figure Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis

Table Raw Materials Sources of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Players/Manufacturers in 2016

Table Major Buyers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Table Distributors/Traders List

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (%) Forecast (2017-2022)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) Trend Forecast (2017-2022)

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast by Type (2017-2022)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast by Type (2017-2022)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Market Share Forecast by Type in 2022

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast by Application (2017-2022)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Market Share Forecast by Application (2017-2022)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Market Share Forecast by Application in 2022

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast by Regions (2017-2022)

Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Volume Share Forecast by Regions in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources